Medication info
Sitagliptin, Dapagliflozin, Metformin Prolonged-Release Tablets 10/100/1000 mg

Sitagliptin, Dapagliflozin, Metformin Prolonged-Release Tablets 10/100/1000 mg

Prescription medicationTabletOral
Ingredient · strength
Metformin Hydrochloride›1000mg / 1 tabletSitagliptin Phosphate Hydrate›128.5mg / 1 tabletDapagliflozin Propanediol Hydrate›12.3mg / 1 tablet
Manufacturer / importer
Green Cross Corp.
Appearance
Pink oval-shaped prolonged-release film-coated tablets
Packaging
30 tablets per bottle
Approval status
Active

MFDS item code 202401792 · Approved 2024.07.24 · Insurance code 643606740

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended dose of this medicine is 10 mg of dapagliflozin and 100 mg of sitagliptin. The dose of extended-release metformin hydrochloride is determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding 2000 mg. Take this medicine once daily with a meal in the evening. If the dose of metformin hydrochloride needs to be adjusted, adjust it gradually. Take 1 tablet of the 10/100/1000 mg extended-release tablet once daily. Take 2 tablets of the 5/50/500 mg, 5/50/750 mg, and 5/50/1000 mg extended-release tablets once daily. Administer dapagliflozin 10 mg, sitagliptin 100 mg, and the dose of metformin hydrochloride currently being taken or a therapeutically equivalent dose. To maintain the extended-release properties, swallow whole; do not split, crush, grind, or chew. Patients with renal impairment require dose adjustment according to renal function; discontinue treatment if renal function declines.

Ingredients

Manufacturer
Green Cross Corp.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes mellitus

View approved original text

This medication helps manage blood glucose levels in patients with type 2 diabetes when used in combination with dapagliflozin, sitagliptin, and metformin. It is more effective when combined with dietary and exercise therapies, helping to manage blood glucose levels stably. This contributes to improved blood glucose control and diabetes management.

How to take

Adult dose

The recommended dose of this medicine is 10 mg of dapagliflozin and 100 mg of sitagliptin. The dose of extended-release metformin hydrochloride is determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding 2000 mg. Take this medicine once daily with a meal in the evening. If the dose of metformin hydrochloride needs to be adjusted, adjust it gradually. Take 1 tablet of the 10/100/1000 mg extended-release tablet once daily. Take 2 tablets of the 5/50/500 mg, 5/50/750 mg, and 5/50/1000 mg extended-release tablets once daily. Administer dapagliflozin 10 mg, sitagliptin 100 mg, and the dose of metformin hydrochloride currently being taken or a therapeutically equivalent dose. To maintain the extended-release properties, swallow whole; do not split, crush, grind, or chew. Patients with renal impairment require dose adjustment according to renal function; discontinue treatment if renal function declines.

Precautions

This medication contains three components used in diabetes treatment: dapagliflozin, sitagliptin, and metformin. First, the sitagliptin component can rarely cause serious allergic reactions, so if symptoms such as skin rash, angioedema, or difficulty breathing occur within three months of administration, treatment should be stopped immediately, and a doctor should be consulted. Additionally, acute pancreatitis may occur, so if symptoms such as abdominal pain, nausea, or vomiting arise, seek medical attention promptly. The metformin component may rarely cause a serious metabolic disorder known as lactic acidosis, which should not be used in patients with diminished kidney function or poor liver function. Symptoms of lactic acidosis include fatigue, muscle pain, difficulty breathing, and abdominal pain; if such symptoms occur, immediate medical attention should be sought. This medication should not be used in patients with moderate to severe renal impairment, dehydration, severe infections, cardiovascular collapse, acute myocardial infarction, sepsis, or other acute conditions that can affect renal function. Also, this medication should be discontinued for a specified period before and after tests involving iodinated contrast agents and should only be resumed after kidney function is confirmed to be normal. This medication carries a risk of decreased fluid volume and hypotension; therefore, patients, especially the elderly or those on diuretics, should be thoroughly assessed for fluid status and renal function before taking it, and blood pressure symptoms and renal function should be regularly monitored during treatment. Also, while taking this medication, genital infections or urinary tract infections may occur, and symptomatic treatment should be sought. Rarely, a serious infection known as perineal necrosis may develop, so if there is pain, swelling, or redness around the genital area, inform medical personnel immediately. This medication can cause hypoglycemia, so especially when used in combination with other antihyperglycemic agents, patients should be alert to symptoms of hypoglycemia. Pregnant women, patients with severe liver dysfunction, acute heart failure, type 1 diabetes, or a history of diabetic ketoacidosis should not take this medication. Finally, it is recommended to regularly monitor kidney and liver function during treatment and to periodically check vitamin B12 levels. Patients taking this medication should consult a doctor or pharmacist immediately if any of the aforementioned symptoms or adverse reactions occur.

Side effects

  • Severe hypersensitivity reactions
  • anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • acute pancreatitis
  • hemorrhagic pancreatitis
  • necrotizing pancreatitis
  • lactic acidosis
  • hypoglycemia
  • genital infections
Show 148 more
  • vulvitis
  • balanitis
  • fungal infections
  • perineal necrosis
  • decreased fluid volume
  • dehydration
  • hypovolemia
  • hypotension
  • diabetic ketoacidosis
  • urinary tract infections
  • cystitis
  • E. coli urinary tract infections
  • genitourinary infections
  • pyelonephritis
  • interstitial cystitis
  • urethritis
  • kidney infections
  • prostatitis
  • elevated hematocrit
  • decreased serum creatinine clearance
  • dyslipidemia
  • elevated serum creatinine
  • elevated blood urea
  • weight loss
  • rash
  • generalized rash
  • pruritic rash
  • maculopapular rash
  • papular rash
  • pustular rash
  • vesicular rash
  • erythematous rash
  • gastroesophageal reflux disease
  • upper abdominal pain
  • diverticulosis
  • intestinal perforation
  • chronic pancreatitis
  • hyperglycemia
  • paresthesia
  • cerebral infarction
  • nerve compression
  • urosepsis
  • acute pyelonephritis
  • asthenia
  • pain
  • ligament sprain
  • road traffic accident
  • drug overdose
  • ankle fracture
  • hand fracture
  • pelvic fracture
  • meniscal injury
  • thoracic spine fracture
  • tibial fracture
  • keratitis
  • chronic obstructive pulmonary disease
  • hemoptysis
  • cerebral hemorrhage
  • peripheral artery occlusion
  • angina
  • myocardial infarction
  • choledocholithiasis
  • cholangitis
  • alcoholic cirrhosis
  • depression
  • suicide attempt
  • gastric adenocarcinoma
  • anaphylactic reaction
  • acute renal failure
  • upper respiratory infections
  • nasopharyngitis
  • constipation
  • vomiting
  • headache
  • severe arthralgia
  • vesicular pemphigoid
  • myalgia
  • limb pain
  • back pain
  • interstitial lung disease
  • pruritus
  • thrombocytopenia
  • rhabdomyolysis
  • dyspepsia
  • nausea
  • diarrhea
  • urinary retention
  • elevated alanine aminotransferase
  • elevated aspartate aminotransferase
  • decreased appetite
  • headache
  • nasopharyngitis
  • asthenia
  • hunger
  • vaginal discharge
  • itching
  • urticaria
  • sweating
  • arthralgia
  • musculoskeletal pain
  • limb pain
  • muscle weakness
  • myalgia
  • osteoarthritis
  • contusion
  • orbital fracture
  • foot fracture
  • gastrointestinal foreign body
  • laceration
  • ligament tear
  • skin abrasion
  • tendon rupture
  • dry eye
  • eye pain
  • retinal disorders
  • visual impairment
  • blepharitis
  • cataract
  • conjunctival edema
  • allergic conjunctivitis
  • conjunctivitis
  • diplopia
  • eyelid edema
  • glaucoma
  • visual disability
  • vitreous floaters
  • oropharyngeal pain
  • allergic rhinitis
  • asthma
  • vocal impairment
  • epistaxis
  • sputum
  • sleep apnea syndrome
  • wheezing
  • atherosclerosis
  • flushing
  • peripheral coldness
  • varicose veins
  • vascular headache
  • orthostatic hypotension
  • palpitations
  • insomnia
  • fatty liver
  • gallbladder polyp
  • tinnitus
  • taste impairment
  • erythema
  • rash

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent exposure to air and moisture, and it is recommended to keep it at room temperature between 1 to 30 degrees Celsius. Storing it this way helps to maintain the medication's efficacy and prevent degradation.

Appearance and packaging

Appearance

Pink oval-shaped prolonged-release film-coated tablets

Package unit

30 tablets per bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.